PRagMatic Pediatric Trial of Balanced vs nOrmaL Saline FlUid in Sepsis: study protocol for the PRoMPT BOLUS randomized interventional trial

Simple item page
dc.contributor.authorWeiss, Scott L.
dc.contributor.authorBalamuth, Fran
dc.contributor.authorLong, Elliot
dc.contributor.authorThompson, Graham C.
dc.contributor.authorHayes, Katie L.
dc.contributor.authorKatcoff, Hannah
dc.contributor.authorCook, Marlena
dc.contributor.authorTsemberis, Elena
dc.contributor.authorHickey, Christopher P.
dc.contributor.authorWilliams, Amanda
dc.contributor.authorWilliamson-Urquhart, Sarah
dc.contributor.authorBorland, Meredith L.
dc.contributor.authorDalziel, Stuart R.
dc.contributor.authorGelbart, Ben
dc.contributor.authorFreedman, Stephen B.
dc.contributor.authorBabl, Franz E.
dc.contributor.authorHuang, Jing
dc.contributor.authorKuppermann, Nathan
dc.date.accessioned2021-11-07T01:02:39Z
dc.date.available2021-11-07T01:02:39Z
dc.date.issued2021-11-06
dc.date.updated2021-11-07T01:02:39Z
dc.description.abstractAbstract Background/aims Despite evidence that preferential use of balanced/buffered fluids may improve outcomes compared with chloride-rich 0.9% saline, saline remains the most commonly used fluid for children with septic shock. We aim to determine if resuscitation with balanced/buffered fluids as part of usual care will improve outcomes, in part through reduced kidney injury and without an increase in adverse effects, compared to 0.9% saline for children with septic shock. Methods The Pragmatic Pediatric Trial of Balanced versus Normal Saline Fluid in Sepsis (PRoMPT BOLUS) study is an international, open-label pragmatic interventional trial being conducted at > 40 sites in the USA, Canada, and Australia/New Zealand starting on August 25, 2020, and continuing for 5 years. Children > 6 months to < 18 years treated for suspected septic shock with abnormal perfusion in an emergency department will be randomized to receive either balanced/buffered crystalloids (intervention) or 0.9% saline (control) for initial resuscitation and maintenance fluids for up to 48 h. Eligible patients are enrolled and randomized using serially numbered, opaque envelopes concurrent with clinical care. Given the life-threatening nature of septic shock and narrow therapeutic window to start fluid resuscitation, patients may be enrolled under “exception from informed consent” in the USA or “deferred consent” in Canada and Australia/New Zealand. Other than fluid type, all decisions about timing, volume, and rate of fluid administration remain at the discretion of the treating clinicians. For pragmatic reasons, clinicians will not be blinded to study fluid type. Anticipated enrollment is 8800 patients. The primary outcome will be major adverse kidney events within 30 days (MAKE30), a composite of death, renal replacement therapy, and persistent kidney dysfunction. Additional effectiveness, safety, and biologic outcomes will also be analyzed. Discussion PRoMPT BOLUS will provide high-quality evidence for the comparative effectiveness of buffered/balanced crystalloids versus 0.9% saline for the initial fluid management of children with suspected septic shock in emergency settings. Trial registration PRoMPT BOLUS was first registered at ClinicalTrials.gov ( NCT04102371 ) on September 25, 2019. Enrollment started on August 25, 2020.
dc.identifier.citationTrials. 2021 Nov 06;22(1):776
dc.identifier.doihttps://doi.org/10.1186/s13063-021-05717-4
dc.identifier.urihttp://hdl.handle.net/1880/114101
dc.language.rfc3066en
dc.rights.holderThe Author(s)
dc.titlePRagMatic Pediatric Trial of Balanced vs nOrmaL Saline FlUid in Sepsis: study protocol for the PRoMPT BOLUS randomized interventional trial
dc.typeJournal Article
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
13063_2021_Article_5717.pdf
Size:
1.37 MB
Format:
Adobe Portable Document Format
Description:
Download
License bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
license.txt
Size:
0 B
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Open Access Publications